The article highlights a whale taking a bullish stance on Amgen, with 54% of investors opening trades with bullish expectations. This indicates a positive sentiment towards the stock, which is currently up 0.74% at $225.64. The whale's target price range of $220 to $250 over the last 3 months also supports the bullish outlook. This information is relevant and important for investors in Amgen, and the confidence in the analysis is high due to the clear data presented in the article.